BPA Call 36C25218A0045-36C25221N0409

This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to INO Therapeutics LLC, a company that provides inhaled nitric oxide therapy systems and related medical gases. The contract is for the delivery of NITRIC OXIDE MEDICAL GAS with an ultimate completion date of September 30, 2024 and a ceiling value of $29,571.60. The contract was awarded without a set-aside designation and is under the Pharmaceuticals and Drugs GSA...

This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to INO Therapeutics LLC, a foreign-owned for-profit company. The contract, which is a Blanket Purchase Agreement (BPA) Call under the Pharmaceuticals and Drugs GSA Schedule, is for the provision of inhaled nitric oxide therapy services. The contract has a potential value of $136,808.70 and a completion date of May 31, 2022. INO Therapeutics LLC has been awarded over 50 federal contracts...

This federal contract award is for THERAPEUTIC NITRIC OXIDE SUPPLIES to the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract was awarded to INO Therapeutics LLC, a foreign-owned, for-profit organization, on September 21, 2017 with a ceiling value of $286,719.70. The contract is a Delivery Order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule (FSS-61-IB) and has a Firm Fixed Price pricing type. The contract supports the...

This federal contract was awarded by the Department of the Army Medical Command to INO Therapeutics LLC, a prime contractor, to provide the purchase of nitric oxide respiratory gas from October 1, 2017 through September 30, 2018. The contract was placed under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and had a firm fixed price. The potential value of the contract was $143,329.42. There was no set-aside designation used for this award. INO Therapeutics LLC is a foreign-owned,...

INO Therapeutics LLC has been awarded a $79,271 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to provide nitric oxide therapeutic gas services. The contract was awarded off the Pharmaceuticals and Drugs GSA Supply Schedule without a set-aside designation. INO Therapeutics will supply nitric oxide cylinders, gases, delivery machines, labor, and equipment to support respiratory treatments at VA...

Premier & Companies, Inc. was awarded a blanket purchase agreement (BPA) call against its Multiple Award Schedule contract with the General Services Administration Federal Acquisition Service. The BPA call is to provide calibration gas for nitric oxide in 74-liter cylinders. With a start date of June 27, 2023 and end date of July 25, 2023, the fixed price with economic price adjustment contract is valued at approximately $100,000. Funding is provided by GSA FAS to support its RC2 program....

This is a contract award to INO Therapeutics LLC, a foreign-owned for-profit organization, by the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs GSA Schedule, with a ceiling value of $50,000.00 and an ultimate completion date of September 30, 2027. The contract type is Firm Fixed Price. The award is not associated with a set-aside program. The contract involves the delivery of inhaled nitric oxide therapy...

The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price delivery order contract to INO Therapeutics LLC, a foreign-owned, for-profit organization, to provide INO (nitric oxide) therapy for term and near-term neonates. The $204,710.00 contract was awarded on October 1, 2019, with a completion date of September 30, 2020. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and did not have a set-aside designation. INO Therapeutics is...

This delivery order, awarded by the Department of the Army Medical Command to INO Therapeutics LLC, is for the purchase of nitric oxide respiratory gas from October 1, 2018 through September 30, 2019. The firm fixed price contract, valued at one hundred forty-nine thousand eight hundred ninety dollars and eighty cents ($149,890.80), utilizes the Pharmaceuticals and Drugs schedule under the General Services Administration (GSA) multiple award schedule contracts to acquire the product, with...

INO Therapeutics LLC has been awarded a $100,028.75 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Supply Schedule to provide nitric oxide respiratory gas from October 1, 2020 to September 30, 2021 for the Department of the Army Medical Command. As the prime contractor, INO Therapeutics will supply inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments at the place of performance in Hampton, New Jersey. INO Therapeutics...